Medpace Holdings (MEDP) earnings per share (EPS)

Earnings per share · fiscal 2025
$15.28

Medpace Holdings (MEDP) reported diluted earnings per share of $15.28 in fiscal 2025 (the year ended December 31, 2025). That is 21.0% higher than the $12.63 of fiscal 2024. Figures as of 17 Nov 2026, 20:57 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings per share, fiscal 2025
$15.28
Change on fiscal 2024
+21.0%
Growth, 5 years
+31.8% a year
Highest on record
$15.28fiscal 2025
Lowest on record
-$0.28fiscal 2015
Fiscal years on record
112015–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Medpace Holdings earnings per share (EPS), in more detail

Over the five fiscal years to 2025 diluted earnings per share grew at a compound 31.8% a year. Across the 11 fiscal years on record (2015–2025), the highest was $15.28 in fiscal 2025 and the lowest -$0.28 in fiscal 2015.

History · 11 fiscal years

Earnings per share by fiscal year

Medpace Holdings earnings per share (EPS), year by year

Medpace Holdings (MEDP) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2025$15.28 21.0% up
2024$12.63 42.2% up
2023$8.88 22.0% up
2022$7.28 51.4% up
2021$4.81 25.3% up
2020$3.84 43.8% up
2019$2.67 35.5% up
2018$1.97 101.0% up
2017$0.98 164.9% up
2016$0.37—
2015-$0.28—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

Earnings per share at health care companies of similar size

Earnings per share of Medpace Holdings and comparable companies
CompanyEarnings per shareFiscal year
Alnylam Pharmaceuticals ALNY$2.332025
Zimmer Biomet Holdings ZBH$3.552025
Medpace Holdings MEDP$15.282025
Revvity RVTY$2.072025
Exelixis EXEL$2.782025
Charles River Laboratories International CRL-$2.912025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on MEDP

Medpace Holdings, figure by figure

Medpace Holdings (MEDP) overview: price, valuation and scorecardAll health care companies by market value

Medpace Holdings earnings per share (EPS): questions and answers

What is Medpace Holdings's diluted earnings per share?

Medpace Holdings (MEDP) reported diluted earnings per share of $15.28 in fiscal 2025 (the year ended December 31, 2025). That is 21.0% higher than the $12.63 of fiscal 2024.

What is the growth rate of Medpace Holdings's diluted earnings per share?

Over the five fiscal years to 2025 diluted earnings per share grew at a compound 31.8% a year.

What are the highest and lowest diluted earnings per share figures on record for Medpace Holdings?

Across the 11 fiscal years on record (2015–2025), the highest was $15.28 in fiscal 2025 and the lowest -$0.28 in fiscal 2015.

How is Medpace Holdings's diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Medpace Holdings (MEDP) earnings per share (EPS)”, data as of 17 November 2026. https://funkfolio.com/stock/MEDP/eps

Underlying data: the company's filings with the SEC and Yahoo Finance.